Literature DB >> 30383234

Viral Genetics Modulate Orolabial Herpes Simplex Virus Type 1 Shedding in Humans.

Meena S Ramchandani1, Lichen Jing1, Ronnie M Russell1, Tran Tran1, Kerry J Laing1, Amalia S Magaret2,3,4, Stacy Selke2,3, Anqi Cheng3, Meei-Li Huang2, Hong Xie2, Eric Strachan5, Alex L Greninger2, Pavitra Roychoudhury2, Keith R Jerome2,4, Anna Wald1,6,2,4, David M Koelle1,2,7,4,8.   

Abstract

BACKGROUND: Orolabial herpes simplex virus type 1 (HSV-1) infection has a wide spectrum of severity in immunocompetent persons. To study the role of viral genotype and host immunity, we characterized oral HSV-1 shedding rates and host cellular response, and genotyped viral strains, in monozygotic (MZ) and dizygotic (DZ) twins.
METHODS: A total of 29 MZ and 22 DZ HSV-1-seropositive twin pairs were evaluated for oral HSV-1 shedding for 60 days. HSV-1 strains from twins were genotyped as identical or different. CD4+ T-cell responses to HSV-1 proteins were studied.
RESULTS: The median per person oral HSV shedding rate was 9% of days that a swab was obtained (mean, 10.2% of days). A positive correlation between shedding rates was observed within all twin pairs, and in the MZ and DZ twins. In twin subsets with sufficient HSV-1 DNA to genotype, 15 had the same strain and 14 had different strains. Viral shedding rates were correlated for those with the same but not different strains. The median number of HSV-1 open reading frames recognized per person was 16. The agreement in the CD4+ T-cell response to specific HSV-1 open reading frames was greater between MZ twins than between unrelated persons (P = .002).
CONCLUSION: Viral strain characteristics likely contribute to oral HSV-1 shedding rates.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD4 T cells; Herpes simplex virus; cold sores; herpes labialis; twins

Mesh:

Year:  2019        PMID: 30383234      PMCID: PMC6420167          DOI: 10.1093/infdis/jiy631

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  54 in total

1.  Verification of self-report of zygosity determined via DNA testing in a subset of the NAS-NRC twin registry 40 years later.

Authors:  Terry Reed; Brenda L Plassman; Caroline M Tanner; Danielle M Dick; Shannon A Rinehart; William C Nichols
Journal:  Twin Res Hum Genet       Date:  2005-08       Impact factor: 1.587

2.  Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening.

Authors:  Kaustuv Nayak; Lichen Jing; Ronnie M Russell; D Huw Davies; Gary Hermanson; Douglas M Molina; Xiaowu Liang; David R Sherman; William W Kwok; Junbao Yang; John Kenneth; Syed F Ahamed; Anmol Chandele; Kaja Murali-Krishna; David M Koelle
Journal:  Tuberculosis (Edinb)       Date:  2015-03-27       Impact factor: 3.131

3.  Diagnosis of zygosity by questionnaire and polymarker polymerase chain reaction in young twins.

Authors:  W J Chen; H W Chang; M Z Wu; C C Lin; C Chang; Y N Chiu; W T Soong
Journal:  Behav Genet       Date:  1999-03       Impact factor: 2.805

4.  Dynamics of the cytotoxic T cell response to a model of acute viral infection.

Authors:  William S DeWitt; Ryan O Emerson; Paul Lindau; Marissa Vignali; Thomas M Snyder; Cindy Desmarais; Catherine Sanders; Heidi Utsugi; Edus H Warren; Juliana McElrath; Karen W Makar; Anna Wald; Harlan S Robins
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

5.  Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture.

Authors:  Anna Wald; Meei-Li Huang; David Carrell; Stacy Selke; Lawrence Corey
Journal:  J Infect Dis       Date:  2003-10-31       Impact factor: 5.226

6.  Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavity.

Authors:  S L Spruance
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

7.  Early acquisition of herpes simplex virus type 1 antibodies in children--a longitudinal serological study.

Authors:  Petra Tunbäck; Tomas Bergström; Bo A Claesson; Rose-Marie Carlsson; Gun-Britt Löwhagen
Journal:  J Clin Virol       Date:  2007-07-20       Impact factor: 3.168

8.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

Authors:  R L Ashley; J Militoni; F Lee; A Nahmias; L Corey
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

9.  Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012.

Authors:  Katharine J Looker; Amalia S Magaret; Margaret T May; Katherine M E Turner; Peter Vickerman; Sami L Gottlieb; Lori M Newman
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

10.  Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control.

Authors:  Gerit Korr; Michael Thamm; Irina Czogiel; Christina Poethko-Mueller; Viviane Bremer; Klaus Jansen
Journal:  BMC Infect Dis       Date:  2017-07-06       Impact factor: 3.090

View more
  10 in total

Review 1.  Herpes Simplex Virus Latency Is Noisier the Closer We Look.

Authors:  Navneet Singh; David C Tscharke
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

2.  Comparison of herpes simplex virus 1 genomic diversity between adult sexual transmission partners with genital infection.

Authors:  Molly M Rathbun; Mackenzie M Shipley; Christopher D Bowen; Stacy Selke; Anna Wald; Christine Johnston; Moriah L Szpara
Journal:  PLoS Pathog       Date:  2022-05-19       Impact factor: 7.464

3.  Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction Determination.

Authors:  Victoria L Campbell; LeAnn Nguyen; Elise Snoey; Christopher L McClurkan; Kerry J Laing; Lichun Dong; Alessandro Sette; Cecilia S Lindestam Arlehamn; Danny M Altmann; Rosemary J Boyton; Justin A Roby; Michael Gale; Mars Stone; Michael P Busch; Phillip J Norris; David M Koelle
Journal:  Immunohorizons       Date:  2020-08-04

Review 4.  Herpes Simplex Virus Type 1 Interactions with the Interferon System.

Authors:  Kevin Danastas; Monica Miranda-Saksena; Anthony L Cunningham
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

Review 5.  Persistent Infection with Herpes Simplex Virus 1 and Alzheimer's Disease-A Call to Study How Variability in Both Virus and Host may Impact Disease.

Authors:  Colleen A Mangold; Moriah L Szpara
Journal:  Viruses       Date:  2019-10-20       Impact factor: 5.048

Review 6.  Pathogenesis and virulence of herpes simplex virus.

Authors:  Shuyong Zhu; Abel Viejo-Borbolla
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

7.  HSV-2-Specific Human Female Reproductive Tract Tissue Resident Memory T Cells Recognize Diverse HSV Antigens.

Authors:  David M Koelle; Lichun Dong; Lichen Jing; Kerry J Laing; Jia Zhu; Lei Jin; Stacy Selke; Anna Wald; Dana Varon; Meei-Li Huang; Christine Johnston; Lawrence Corey; Christine M Posavad
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 8.786

Review 8.  Alphaherpesvirus Genomics: Past, Present and Future.

Authors:  Chad V Kuny; Moriah L Szpara
Journal:  Curr Issues Mol Biol       Date:  2020-11-07       Impact factor: 2.081

9.  Genital HSV-1 DNA detection is associated with a low inflammatory profile in HIV-uninfected South African women.

Authors:  Andile Mtshali; Sinaye Ngcapu; Farzana Osman; Nigel Garrett; Ravesh Singh; Anne Rompalo; Adrian Mindel; Lenine J P Liebenberg
Journal:  Sex Transm Infect       Date:  2020-08-26       Impact factor: 3.519

Review 10.  Local Immune Control of Latent Herpes Simplex Virus Type 1 in Ganglia of Mice and Man.

Authors:  Anthony J St Leger; David M Koelle; Paul R Kinchington; Georges Michel G M Verjans
Journal:  Front Immunol       Date:  2021-09-15       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.